Dolby Laboratories (NYSE:DLB) – Analysts at Barrington Research issued their Q1 2019 EPS estimates for Dolby Laboratories in a research note issued to investors on Monday. Barrington Research analyst J. Goss expects that the electronics maker will post earnings of $0.47 per share for the quarter. Barrington Research also issued estimates for Dolby Laboratories’ Q2 2019 earnings at $0.59 EPS and Q3 2019 earnings at $1.08 EPS.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, October 25th. The electronics maker reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.18. The company had revenue of $242.05 million for the quarter, compared to analyst estimates of $244.80 million. Dolby Laboratories had a return on equity of 10.73% and a net margin of 18.66%. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.37 earnings per share.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/q1-2019-earnings-forecast-for-dolby-laboratories-issued-by-barrington-research-dlb/1676260.html.

DLB has been the topic of a number of other research reports. B. Riley reissued a “buy” rating and issued a $65.50 target price on shares of Dolby Laboratories in a research report on Thursday, October 26th. BidaskClub lowered Dolby Laboratories from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 22nd. Dougherty & Co reissued a “buy” rating and issued a $63.00 target price on shares of Dolby Laboratories in a research report on Wednesday, September 13th. Piper Jaffray Companies reissued a “hold” rating and issued a $52.00 target price (up previously from $49.00) on shares of Dolby Laboratories in a research report on Wednesday, September 13th. Finally, Zacks Investment Research lowered Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $60.17.

Shares of Dolby Laboratories (NYSE DLB) traded up $0.68 during midday trading on Wednesday, reaching $59.03. The company’s stock had a trading volume of 204,519 shares, compared to its average volume of 378,905. The company has a market capitalization of $5,984.47, a PE ratio of 28.20 and a beta of 0.83.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, November 6th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, November 3rd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.08%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.14. Dolby Laboratories’s dividend payout ratio is currently 28.87%.

In other news, major shareholder Dagmar Dolby sold 100,000 shares of the company’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $51.13, for a total transaction of $5,113,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Kevin J. Yeaman sold 45,000 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $56.46, for a total value of $2,540,700.00. The disclosure for this sale can be found here. Insiders have sold 1,174,665 shares of company stock worth $59,548,880 in the last ninety days. Corporate insiders own 43.80% of the company’s stock.

Several institutional investors have recently bought and sold shares of DLB. Spot Trading L.L.C. purchased a new stake in shares of Dolby Laboratories during the first quarter worth $660,000. Ameriprise Financial Inc. grew its stake in shares of Dolby Laboratories by 0.4% during the first quarter. Ameriprise Financial Inc. now owns 15,650 shares of the electronics maker’s stock worth $821,000 after purchasing an additional 61 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Dolby Laboratories by 1.2% during the first quarter. Wellington Management Group LLP now owns 19,240 shares of the electronics maker’s stock worth $1,008,000 after purchasing an additional 219 shares in the last quarter. Teachers Advisors LLC grew its stake in shares of Dolby Laboratories by 5.5% during the first quarter. Teachers Advisors LLC now owns 138,445 shares of the electronics maker’s stock worth $7,256,000 after purchasing an additional 7,209 shares in the last quarter. Finally, Legal & General Group Plc grew its stake in shares of Dolby Laboratories by 129.3% during the first quarter. Legal & General Group Plc now owns 18,387 shares of the electronics maker’s stock worth $964,000 after purchasing an additional 10,368 shares in the last quarter. 51.83% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.